Paxton Bach

Clinical Assistant Professor

The University of British Columbia

Canada

Research Interests

Explore related searches

Professors in Canada

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Paxton Bach is a Clinical Assistant Professor at the University of British Columbia, Canada. His research primarily focuses on opioid use disorder, health service utilization, and substance use treatment outcomes. Recent articles authored by Professor Bach explore critical issues such as the impact of hepatitis C on health service utilization and the effectiveness of drug testing schedules in opioid agonist therapy.

Articles (21)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (5)

Jacquelyn Cragg

Assistant Professor & Tier 2 Canada Research Chair in Open Data Science

The University of British Columbia

CANADA

View details

Richard Saitz

UNITED STATES

View details

Jan Klimas

The University of British Columbia

CANADA

View details

M. Eugenia Socias

University of British Columbia Faculty of Medicine

CANADA

View details

Paul Gustafson

Professor

The University of British Columbia

CANADA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Paxton Bach

Research Interests

Explore related searches

Contact this professor

About

Articles (21)

Impact of hepatitis C serostatus on health service utilization for opioid-related harms among individuals prescribed opioid agonist therapy: A longitudinal prospective cohort study

Comparative effectiveness of urine drug testing schedules alongside opioid agonist treatment: Emulation of a population‐based target trial in British Columbia, Canada

Trends in stimulant use among patients with opioid use disorder receiving substance use treatment: Findings from a prospective cohort study from 2013 to 2020

Association between prescribed stimulant medications and overdose among individuals receiving opioid agonist therapy: A retrospective cohort study from British Columbia, Canada

Opioid agonist treatment outcomes among individuals with a history of nonfatal overdose: Findings from a pragmatic, pan‐Canadian, randomized control trial

Fatal Drug Overdose Risks of Health Care Workers in the United States

Prescription psychostimulants for the treatment of amphetamine‐type stimulant use disorder: A systematic review and meta‐analysis of randomized placebo‐controlled trials

Comparative Analysis of Instrumental Variables on the Assignment of Buprenorphine/Naloxone or Methadone for the Treatment of Opioid Use Disorder

Effect of Risk Mitigation Guidance opioid and stimulant dispensations on mortality and acute care visits during dual public health emergencies: retrospective cohort study

The Association Between Self-Reported Anxiety and Retention in Opioid Agonist Therapy: Findings From a Canadian Pragmatic Trial,L’association entre l’anxiété et la rétention auto-déclarées dans la thérapie agoniste opioïde : résultats d’un essai pragmatique canadien

Cases: Multiorgan failure in a 38-year-old man with recent consumption of kratom, an atypical opioid

Amphetamine-Related Emergency Department Visits in Ontario, Canada, 2003-2020,Visites au service d’urgence liées aux amphétamines en Ontario, Canada, 2003-2020

Comparative effectiveness of urine drug screening strategies alongside opioid agonist treatment in British Columbia, Canada: A population-based observational study protocol

Implications of Cannabis Legalization on Substance-Related Benefits and Harms for People Who Use Opioids: A Canadian Perspective

Bupropion for treatment of amphetamine-type stimulant use disorder: A systematic review and meta-analysis of placebo-controlled randomized clinical trials

Advancing virtual primary care for people with opioid use disorder (VPC OUD): a mixed-methods study protocol

Opioid agonist therapy engagement and crystal methamphetamine use: The impact of unregulated opioid use in Vancouver, Canada

Challenges and opportunities for further research involving the cannabis‐to‐opioid use transition

Comparative efficacy and safety of pharmacotherapies for alcohol withdrawal: a systematic review and network meta‐analysis

Amphetamine-related care in the USA, 2003-2014: Cross-sectional analyses examining inpatient trends and factors associated with hospitalisation outcomes

Availability and use of non-prescribed buprenorphine-naloxone in a Canadian setting, 2014–2020

Collaborators (5)

Jacquelyn Cragg

Richard Saitz

Jan Klimas

M. Eugenia Socias

Paul Gustafson

Make your next move.